Related Experiment Videos
Cyclosporin in less common immune-mediated skin diseases
1Department of Dermatology, Heinrich-Heine University, Dusseldorf, Germany.
The British Journal of Dermatology
|September 1, 1996
Abstract:
Cyclosporin represents a major step forward in the systemic treatment of various dermatoses. Psoriasis vulgaris and atopic eczema, the two major indications for the drug, are dealt with elsewhere in this issue. Therefore, this short review will focus on less common inflammatory skin diseases.